The Centers for Disease Control and Prevention (CDC) said those with preexisting health conditions are more at risk of severe illness if they contract COVID-19. Read More »

A fifth COVID-19 vaccine is scheduled to enter a Phase III clinical trial in the coming weeks with 30,000 participants in the United States and Mexico. Read More »

Centene Corporation (NYSE: CNC) announced that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases. Read More »

National Healthcareer Association (NHA) is now partnering with CEimpact to offer pharmacy technicians an ACPE-accredited immunization training option, helping them qualify to administer vaccinations according to the U.S. Department of Health and Human Services' (HHS) Public Readiness and Emergency Preparedness (PREP) Act. Read More »

Managing receivables from Insurance becomes easier for Pharmacies Read More »

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the initiation of a long-term safety extension study (MT-1186-A03) to the ongoing Phase 3 trial evaluating an investigational oral formulation of edaravone in patients with amyotrophic lateral sclerosis (ALS). Read More »

The highly attended virtual trade show series for pharmaceutical manufacturing professionals is returning for two installments in 2021. Read More »

Pharmacists "Again Prepared to Step Forward and Serve as Essential Health Care Providers" Read More »

The U.S. Food and Drug Administration (FDA) recently issued the first emergency use authorization (EUA) allowing the Pfizer-BioNTech COVID-19 vaccine to be distributed in the U.S., according to a release by the FDA. Read More »

The Food and Drug Administration Advisory panel approved the Pfizer-BioNTech COVID-19 vaccine Dec. 10, greenlighting vaccination efforts for priority groups including frontline health care workers, pharmacists and residents at long-term care facilities, the American Pharmacists Association reports. Read More »

Newly launched CPhT-Adv credential supports the expanded roles of the most valuable players on the pharmacy team Read More »

Highlights Lincoln International's leading advisory position in the animal health sector Read More »

The leaders of 18 pharmacy organizations today issued the following statement following the Food and Drug Administration's approval of the first Emergency use Authorization for the COVID-19 vaccine. Read More »

Action from the U.S. Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) has been challenged by the Pharmaceutical Research and Manufacturers of America (PhRMA), Partnership for Safe Medicines (PSM) and Council for Affordable Health Coverage (CAHC) for letting drugs from Canada into the country without the authorization of manufacturers' oversight. Read More »

PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals, the leading RNAi therapeutics company, as a very limited distribution pharmacy partner for new drug OXLUMO™ (lumasiran). Read More »

The U.S. Food and Drug Administration (FDA) approved the first drug to be used for positron emissions tomography (PET) imaging for prostate cancer on Dec. 1. Read More »

Orsini Specialty Pharmacy, a leader in rare diseases and gene therapies, announced that it has been selected by Alnylam® Pharmaceuticals as a limited distribution partner for OXLUMO™ (lumasiran). Read More »

Researchers recently dove into the complex answer behind the question of whether or not the United States or China holds more influence in the Indo-Pacific Region, according to a research brief from the RAND Corporation. Read More »

The AZD1222 COVID-19 vaccine has shown positive early results, according to Astra Zeneca. Read More »

Vivera Pharmaceuticals and Burkhan World today announce financial backing by JR Dallas Wealth Management in support of Vivera's global growth strategies. Read More »